Frankfurt:7D2

Sedana Medical submits market approval application for the drug Sedaconda

STOCKHOLM, Nov. 27, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has submitted an application for market approval for the drug candidate Sedaconda (isoflurane), formerly known as IsoConDa, for inhaled sedation in intensive care. The applica...

2020-11-27 20:35 2863

Week's Top Stories